Search Within

Jonathan Eric Rosenberg

Formats
  1. Meeting Abstract (283)
  2. Journal Article (195)
  3. Review (18)
  4. Correspondence (10)
  5. Editorial (5)
  6. Guidelines (4)
  7. Book Section (2)
  8. Research Letter (2)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (520)
  2. Genitourinary Oncology Service (520)
  3. Solid Tumor Oncology Division (520)
  4. Department of Pathology and Laboratory Medicine (149)
  5. Surgery (140)
  6. Urology (137)

More Groups

People
  1. Dean Bajorin (204)
  2. Gopakumar Iyer (175)
  3. Hikmat Al-Ahmadie (134)
  4. Bernard Bochner (124)
  5. David Solit (114)
  6. Min Yuen Teo (75)

More People

Years
  1. 2025 (23)
  2. 2024 (36)
  3. 2023 (32)
  4. 2022 (36)
  5. 2021 (48)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (204)
  2. Annals of Oncology (42)
  3. European Urology (20)
  4. Clinical Genitourinary Cancer (18)
  5. Clinical Cancer Research (16)
  6. Cancer Research (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (210)
  2. Oxford University Press (47)
  3. Elsevier Inc. (39)
  4. Elsevier Science, Inc. (36)
  5. Nature Publishing Group (36)
  6. American Association for Cancer Research (35)

More Publishers

Results (520)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical-pathologic stage discrepancy in patients with bladder cancer treated with radical cystectomy: Associations with clinical variables and survival
    Meeting Abstract

    Gray, P. J.; Fedewa, S. A.; Shipley, W. U.; Lin, C. C.; Virgo, K. S.; Kibel, A. S.; Kamat, A. M.; Rosenberg, J. E.; Jemal, A.; Zietman, A. L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase II multicenter study of neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) chemotherapy with pegfilgrastim support in patients (pts) muscle-invasive urothelial cancer (MIUC): Safety, pathologic, radiologic, and molecular correlates
    Meeting Abstract

    Choueiri, T. K.; Jacobus, S. J.; Qu, A. Q.; Sweeney, C.; Appleman, L. J.; Tretter, C. P. G.; Bubley, G. J.; Elfiky, A.; Park, R.; Stack, E. C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A comparison of toxicity of gemcitabine versus platinum-based combined chemoradiation for muscle-invasive bladder cancer: The Memorial Sloan-Kettering experience
    Meeting Abstract

    Baliga, S.; Pei, X.; Bajorin, D. F.; Rosenberg, J. E.; Bochner, B.; Kollmeier, M.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • The Borealis-2 clinical trial: A randomized phase II study of OGX-427 plus docetaxel versus docetaxel alone in relapsed/refractory metastatic urothelial cancer
    Meeting Abstract

    Rosenberg, J. E.; Hahn, N. M.; Regan, M. A.; Jacobs, C.; Stewart, P. S.; Choueiri, T. K.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) chemotherapy in patients with muscle-invasive urothelial cancer (MI-UC): Pathologic and radiologic response, serum tumor markers, and DNA excision repair pathway biomarkers in relation to disease-free survival (DFS)
    Meeting Abstract

    Qu, A. Q.; Jacobus, S. J.; Signoretti, S.; Stack, E. C.; Krajewski, K. M.; Rosenberg, J. E.; Choueiri, T. K.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Treatment patterns and outcomes in "real world" patients (pts) with metastatic urothelial cancer (UC)
    Meeting Abstract

    Galsky, M. D.; Chowdhury, S.; Bellmunt, J.; Wong, Y. N.; Recine, F.; Pal, S. K.; Moshier, E. L.; Ladoire, S.; De Giorgi, U.; Yu, E. Y.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Loss of Sh3g12/endophilin A1 is an early event in urothelial carcinoma that regulates malignant behavior
    Meeting Abstract

    Majumdar, S.; Gong, E.; Di Vizio, D.; Dreyfuss, J.; DeGraff, D.; Hager, M.; Park, P.; Bellmunt, J.; Matusik, R.; Rosenberg, J.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • The role of aberrant VHL/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinoma
    Journal Article

    Choueiri, T. K.; Fay, A. P.; Gagnon, R.; Lin, Y.; Bahamon, B.; Brown, V.; Rosenberg, J. E.; Hutson, T. E.; Baker-Neblett, K. L.; Carpenter, C.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Molecular targets on the horizon for kidney and urothelial cancer
    Journal Article

    Bellmunt, J.; Teh, B. T.; Tortora, G.; Rosenberg, J. E.
    Nature Reviews Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Advanced urothelial carcinoma: Overcoming treatment resistance through novel treatment approaches
    Journal Article

    Bambury, R. M.; Rosenberg, J. E.
    Frontiers in Pharmacology (2013)

    Fulltext@MSK | Save